静脈-静脈体外式生命維持装置市場レポート：2030年までの動向、予測、競合分析

静脈-静脈体外式生命維持装置の動向と予測

世界の静脈-静脈体外式生命維持装置市場は、2024年から2030年にかけてCAGR 6.5％で成長すると予測されています。この市場の主な促進要因は、心血管疾患や心肺疾患を患う患者の多さと、老人人口の高い増加です。世界の静脈体外式生命維持装置市場の将来は、病院や診療所市場での機会により有望視されています。

静脈-静脈体外式生命維持装置市場の洞察

Lucintelの予測では、単心室デバイスは、単心室心臓欠陥の有病率の上昇により、予測期間中に最も高い成長が見込まれています。

この市場において、病院は専門的な機器と訓練された人材が病院に多く存在するため、最大のセグメントであり続けると思われます。

北米は、高齢者人口の増加と心肺疾患の有病率の高さから、予測期間中に最も高い成長が見込まれています。

よくある質問

Q1.市場の成長予測は？

A1.世界の静脈-静脈体外式生命維持装置市場は、2024年から2030年にかけてCAGR 6.5%で成長する見込みです。

Q2.市場の成長に影響を与える主な促進要因は？

A2.この市場の主な促進要因は、心血管疾患や心肺疾患を患う患者の多さと、老人人口の高い増加です。

Q3.市場の主要セグメントは？

A3.静脈-静脈体外式生命維持装置市場の将来性は、病院と診療所市場での機会により有望視されています。

Q4.市場の主要企業は？

A4.主な静脈-静脈体外式生命維持装置企業は以下の通り。

• Aquetholding
• Microport Scientific
• Medos Medizintechnik
• Sorin
• Medtronic

Q5.今後、最大となる市場セグメントは？

A5.Lucintelは、単心室デバイスは、単心室心臓欠陥の有病率の上昇により、予測期間中に最も高い成長を示すと予測しています。

Q6.市場において、今後5年間に最大になると予想される地域は？

A6.北米は、高齢者人口の増加と心肺疾患の有病率の高さから、予測期間中に最も高い成長が見込まれます。

Q7.レポートのカスタマイズは可能？

A7.はい、Lucintelは追加費用なしで10%のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界の静脈-静脈体外生命維持装置市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年～2030年の市場動向と予測分析

• マクロ経済動向（2018年～2023年）と予測（2024年～2030年）
• 世界の静脈-静脈体外生命維持装置市場動向（2018年～2023年）と予測（2024年～2030年）
• 世界の静脈-静脈体外生命維持装置市場、タイプ別
  • 単心室デバイス
  • 両心室デバイス
• 世界の静脈-静脈体外生命維持装置市場、用途別
  • 大腿静脈
  • 頸静脈
  • 右心房
  • その他
• 世界の静脈-静脈体外生命維持装置市場、最終用途産業別
  • 病院
  • クリニック
  • その他

第4章 2018年～2030年の地域別の市場動向と予測分析

• 地域別の世界の静脈-静脈体外生命維持装置市場
• 北米の静脈-静脈体外生命維持装置市場
• 欧州の静脈体外生命維持装置市場
• アジア太平洋の静脈-静脈体外生命維持装置市場
• その他地域の静脈-静脈体外生命維持装置市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • タイプ別の世界の静脈-静脈体外生命維持装置市場の成長機会
  • 用途別の世界の静脈-静脈体外生命維持装置市場の成長機会
  • 最終用途産業別の世界の静脈-静脈体外生命維持装置市場の成長機会
  • 地域別の世界の静脈-静脈体外生命維持装置市場の成長機会
• 世界の静脈-静脈体外生命維持装置市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の静脈－体外生命維持装置市場の能力拡大
  • 世界の静脈-静脈体外生命維持装置市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• AQUETHolding
• Microport Scientific
• Medos Medizintechnik
• Sorin
• Medtronic

Veno-Venous Extracorporeal Life Support Device Trends and Forecast

The future of the global veno-venous extracorporeal life support device market looks promising with opportunities in the hospitals and clinic markets. The global veno-venous extracorporeal life support device market is expected to grow with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are large number of patient suffering from cardiovascular and cardiopulmonary diseases and high growth of geriatric population.

A more than 150-page report is developed to help in your business decisions.

Veno-Venous Extracorporeal Life Support Device by Segment

The study includes a forecast for the global veno-venous extracorporeal life support device by type, application, end use industry, and region.

Veno-Venous Extracorporeal Life Support Device Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Single-Ventricular Device
• Biventricular Device

Veno-Venous Extracorporeal Life Support Device Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Femoral Vein
• Jugular Vein
• Right Atrium
• Others

Veno-Venous Extracorporeal Life Support Device Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Clinics
• Others

Veno-Venous Extracorporeal Life Support Device Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Veno-Venous Extracorporeal Life Support Device Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies veno-venous extracorporeal life support device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the veno-venous extracorporeal life support device companies profiled in this report include-

• Aquetholding
• Microport Scientific
• Medos Medizintechnik
• Sorin
• Medtronic

Veno-Venous Extracorporeal Life Support Device Market Insights

Lucintel forecasts that single-ventricular devices is expected to witness highest growth over the forecast period due to rising prevalence of single-ventricle heart defects.

Within this market, hospitals will remain the largest segment due to high availability of specialized equipment and trained personnel in hospitals.

North America is expected to witness highest growth over the forecast period due to rising elderly population and high prevalence of cardiopulmonary disease.

Features of the Global Veno-Venous Extracorporeal Life Support Device Market

Market Size Estimates: Veno-venous extracorporeal life support device market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Veno-venous extracorporeal life support device market size by type, application, end use industry, and region in terms of value ($B).

Regional Analysis: Veno-venous extracorporeal life support device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, application, end use industry, and regions for the veno-venous extracorporeal life support device market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the veno-venous extracorporeal life support device market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for veno-venous extracorporeal life support device market?

Answer: The global veno-venous extracorporeal life support device market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the veno-venous extracorporeal life support device market?

Answer: The major drivers for this market are large number of patient suffering from cardiovascular and cardiopulmonary diseases and high growth of geriatric population.

Q3. What are the major segments for veno-venous extracorporeal life support device market?

Answer: The future of the veno-venous extracorporeal life support device market looks promising with opportunities in the hospitals and clinic markets.

Q4. Who are the key veno-venous extracorporeal life support device market companies?

Answer: Some of the key veno-venous extracorporeal life support device companies are as follows.

• Aquetholding
• Microport Scientific
• Medos Medizintechnik
• Sorin
• Medtronic

Q5. Which veno-venous extracorporeal life support device market segment will be the largest in future?

Answer: Lucintel forecasts that single-ventricular devices is expected to witness highest growth over the forecast period due to rising prevalence of single-ventricle heart defects.

Q6. In veno-venous extracorporeal life support device market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to rising elderly population and high prevalence of cardiopulmonary disease.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the veno-venous extracorporeal life support device market by type (single-ventricular device and biventricular device), application (femoral vein, jugular vein, right atrium, and others), end use industry (hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Veno-Venous Extracorporeal Life Support Device Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Veno-Venous Extracorporeal Life Support Device Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Veno-Venous Extracorporeal Life Support Device Market by Type
  • 3.3.1: Single-Ventricular Device
  • 3.3.2: Biventricular Device
• 3.4: Global Veno-Venous Extracorporeal Life Support Device Market by Application
  • 3.4.1: Femoral Vein
  • 3.4.2: Jugular Vein
  • 3.4.3: Right Atrium
  • 3.4.4: Others
• 3.5: Global Veno-Venous Extracorporeal Life Support Device Market by End Use Industry
  • 3.5.1: Hospitals
  • 3.5.2: Clinics
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Veno-Venous Extracorporeal Life Support Device Market by Region
• 4.2: North American Veno-Venous Extracorporeal Life Support Device Market
  • 4.2.2: North American Veno-Venous Extracorporeal Life Support Device Market by End Use Industry: Hospitals, Clinics, and Others
• 4.3: European Veno-Venous Extracorporeal Life Support Device Market
  • 4.3.1: European Veno-Venous Extracorporeal Life Support Device Market by Type: Single-Ventricular Device and Biventricular Device
  • 4.3.2: European Veno-Venous Extracorporeal Life Support Device Market by End Use Industry: Hospitals, Clinics, and Others
• 4.4: APAC Veno-Venous Extracorporeal Life Support Device Market
  • 4.4.1: APAC Veno-Venous Extracorporeal Life Support Device Market by Type: Single-Ventricular Device and Biventricular Device
  • 4.4.2: APAC Veno-Venous Extracorporeal Life Support Device Market by End Use Industry: Hospitals, Clinics, and Others
• 4.5: ROW Veno-Venous Extracorporeal Life Support Device Market
  • 4.5.1: ROW Veno-Venous Extracorporeal Life Support Device Market by Type: Single-Ventricular Device and Biventricular Device
  • 4.5.2: ROW Veno-Venous Extracorporeal Life Support Device Market by End Use Industry: Hospitals, Clinics, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Veno-Venous Extracorporeal Life Support Device Market by Type
  • 6.1.2: Growth Opportunities for the Global Veno-Venous Extracorporeal Life Support Device Market by Application
  • 6.1.3: Growth Opportunities for the Global Veno-Venous Extracorporeal Life Support Device Market by End Use Industry
  • 6.1.4: Growth Opportunities for the Global Veno-Venous Extracorporeal Life Support Device Market by Region
• 6.2: Emerging Trends in the Global Veno-Venous Extracorporeal Life Support Device Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Veno-Venous Extracorporeal Life Support Device Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Veno-Venous Extracorporeal Life Support Device Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: AQUETHolding
• 7.2: Microport Scientific
• 7.3: Medos Medizintechnik
• 7.4: Sorin
• 7.5: Medtronic